InterCure Stock (NASDAQ:INCR)
Previous Close
$5.39
52W Range
$3.40 - $8.45
50D Avg
$4.97
200D Avg
$4.81
Market Cap
$62.19M
Avg Vol (3M)
$27.05K
Beta
0.59
Div Yield
-
INCR Company Profile
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.